These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22228255)
1. Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era. Tzvetkov M; von Ahsen N Pathology; 2012 Feb; 44(2):166-80. PubMed ID: 22228255 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in biological perspective. Kalow W Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in clinical practice: considerations for testing. Constable S; Johnson MR; Pirmohamed M Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics and therapeutic strategies for dementia. Cacabelos R Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004 [TBL] [Abstract][Full Text] [Related]
5. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? Lango H; Weedon MN J Intern Med; 2008 Jan; 263(1):16-27. PubMed ID: 18088250 [TBL] [Abstract][Full Text] [Related]
6. Methodological and statistical issues in pharmacogenomics. Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and the concept of individualized medicine. Shastry BS Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in Alzheimer's disease. Cacabelos R Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenomics genomics approaches to optimizing drug therapy]. Shi J; Chen S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596 [TBL] [Abstract][Full Text] [Related]
10. Human genetic variation and personalized medicine. Agrawal S; Khan F Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing. Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic discovery approaches: will the real genes please stand up? Walgren RA; Meucci MA; McLeod HL J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062 [TBL] [Abstract][Full Text] [Related]
18. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341 [TBL] [Abstract][Full Text] [Related]
19. SNP databases and pharmacogenetics: great start, but a long way to go. Marsh S; Kwok P; McLeod HL Hum Mutat; 2002 Sep; 20(3):174-9. PubMed ID: 12203989 [TBL] [Abstract][Full Text] [Related]
20. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies. Grant SF; Hakonarson H Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]